Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/192645
GGPS1 Mutation and Atypical Femoral Fractures with Bisphosphonates
Títol de la revista
Director/Tutor
Contribució addicional
ISSN de la revista
Títol del volum
Resum
Atypical femoral fractures have been associated with long-term bisphosphonate treatment.1,2 However, the underlying mechanisms remain obscure. We studied three sisters who had atypical femoral fractures after receiving various oral bisphosphonates for 6 years. Two of the sisters had a single fracture (at the ages of 64 and 73 years), and one had bilateral fractures (one at the age of 60 years and the other at the age of 61 years). Given the low incidence of atypical femoral fractures in the general population (5.9 per 10,000 person-years),3 we hypothesized that these sisters might have an underlying genetic background that contributed to these fractures.
Recurs relacionat
Matèries
Matèries (anglès)
Citació
Citació
ROCA AYATS, Neus, et al. GGPS1 Mutation and Atypical Femoral Fractures with Bisphosphonates. New England Journal of Medicine. 2017. Vol. 376, num. 18, pags. 1794-1795. ISSN 0028-4793. [consulted: 11 of October of 2026]. Available at: https://hdl.handle.net/2445/192645